<DOC>
	<DOCNO>NCT01813591</DOCNO>
	<brief_summary>This small study investigate efficacy Acthar treatment chronic migraine patient fail multiple treatment , include Botox ( define &lt; 30 % reduction baseline number headache day per month ) . Despite widespread use anti-seizure medication , remain significant number patient whose migraine refractory agent . The pathophysiology migraine neural substance calcitonin G related protein ( CGRP ) , substance P , neurokinin A release trigeminal nerve ending innervate large cranial dura mater blood vessel neurotrasmission generate migraine associate pain . Because , treatment migraine direct towards regulate receptor site accordingly . Acthar may provide pain relief mechanist , ACTH show inhibit release CGRP may also provide relief negative feedback loop exogenous ACTH inhibit CRH release mast cell degranulation .</brief_summary>
	<brief_title>A Two-Arm Study Evaluation H.P . Acthar Injection Gel Treatment Chronic Migraines</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Adrenocorticotropic Hormone</mesh_term>
	<criteria>Is male female , 18 60 year age . Has history chronic migraine classify International Headache Classification , ICHD2R ( i.e . must demonstrate average &gt; =15 headache day per month , &gt; =8 must migraine day &gt; =8 day migrainespecific acute medicationergotamine triptans least 3 month prior study . Must demonstrate least &gt; =8 migraine day &gt; =8 day migraine specific acute medication ergotamine triptans 30 day baseline screening . Is able differentiate migraine headache may experience ( e.g. , tensiontype headache ) . Will previous history fail least one prophylactic treatment , include antiseizure medication and/or TCA 's prescribed treatment chronic migraine . Must consider nonresponder previous treatment Botox . Botox failure define previous documentation ( discretion PI ) less 30 % reduction headache day per month Botox . Will botulinum toxin 4 month study enrollment . If female childbearing potential , negative urine pregnancy test Visits 1 7 , us , agrees use , duration study , medically acceptable form contraception determine investigator . 1 . Complete abstinence intercourse 2 week prior administration study drug throughout study , time interval completion premature discontinuation study account elimination study drug ( minimum 7 day ) ; , 2 . Surgically sterile ( hysterectomy tubal ligation otherwise incapable pregnancy ) ; , 3 . Sterilization male partner ; , 4 . Intrauterine device publish data show low expected failure rate le 1 % per year ; , 5 . Double barrier method ( i.e. , 2 physical barrier OR 1 physical barrier plus spermicide ) least 1 month prior Visit 1 throughout study ; , 6 . Hormonal contraceptive least 3 month prior Visit 1 throughout study . Protocol Number/v.1/06 Jun 2012 7 Must generally good health confirm medical history , baseline physical exam , baseline neurological exam vital sign . Is unable understand study requirement , informed consent , complete headache record require per protocol . Is pregnant , actively try become pregnant , breastfeed . Has significant systemic disease equally painful painful migraine . Has progressive neurological disorder MS. Has history chronic disease immune system MS know immunodeficiency syndrome HIV . Has sensitivity proteins porcine origin . Has know 'new ' diagnosis diabetes mellitus ( screen blood glucose suspicious diabetes [ &gt; equal 126 mg/dL &gt; equal 7 mmol/L fasting ; &gt; equal 200 mg/dL 11.1 mmol/L random test ] patient evaluate diabetes mellitus ) , know 'new ' diagnosis hypothyroidism adequately controlled medication . Has previously take Acthar reason . Has contraindication list Acthar PI . Has history cluster headache , chronic tension type headache , headache due medication use accord IHS guideline , 3 month prior study enrollment baseline phase . Has receive investigative drug 30 day prior enrollment study . Who opinion Principal Investigator condition enrol study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Chronic Migraine</keyword>
	<keyword>Headache</keyword>
	<keyword>Refractory Chronic Migraine</keyword>
</DOC>